HIF isoforms in the skin differentially regulate systemic arterial pressure

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 43, 2013, Pages 17570-17575

  Cowburn, Andrew S ^a,b   Takeda, Norihiko ^b   Boutin, Adam T ^b   Kim, Jung Whan ^b   Sterling, Jane C ^a   Nakasaki, Manando ^b   Southwood, Mark ^c   Goldrath, Ananda W ^b   Jamora, Colin ^b   Nizet, Victor ^d   Chilvers, Edwin R ^a   Johnson, Randall S ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c PAPWORTH HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Arginase; HIF alpha; Vascular tone

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; AUTOREGULATION; EXERCISE; HOMEOSTASIS; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEMPERATURE ACCLIMATIZATION; TISSUE PERFUSION;

ARGINASE; HIF-ALPHA; VASCULAR TONE;

ADULT; AGED; ANIMALS; ARGINASE; ARTERIAL PRESSURE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; FEMALE; HUMANS; HYPERTENSION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; REGIONAL BLOOD FLOW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; YOUNG ADULT;

EID: 84886414629     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1306942110     Document Type: Article

References (43)

1. Duling BR, Klitzman B (1980) Local control of microvascular function: Role in tissue oxygen supply. Annu Rev Physiol 42:373-382.
2. Stewart J, et al. (2004) Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure. Am J Physiol Heart Circ Physiol 287(6):H2687-H2696.
3. Khan F, Litchfield SJ, Stonebridge PA, Belch JJ (1999) Lipid-lowering and skin vascular responses in patients with hypercholesterolaemia and peripheral arterial obstructive disease. Vasc Med 4(4):233-238.
4. RossiM, Carpi A (2004) Skin microcirculation in peripheral arterial obliterative disease. Biomed Pharmacother 58(8):427-431.
5. Green DJ, et al. (2006) Impaired skin blood flow response to environmental heating in chronic heart failure. Eur Heart J 27(3):338-343.
6. De Ciuceis C, et al. (2007) Structural alterations of subcutaneous small-resistance arteries may predict major cardiovascular events in patients with hypertension. Am J Hypertens 20(8):846-852.
7. Noon JP, et al. (1997) Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 99(8): 1873-1879.
8. Semenza GL (2007) Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. Biochem J 405(1):1-9.
9. Pouysségur J, Dayan F, Mazure NM (2006) Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441(7092):437-443.
10. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3(10):721-732.
11. Gordan JD, Bertout JA, Hu CJ, Diehl JA, Simon MC (2007) HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 11(4): 335-347.
12. Boutin AT, et al. (2008) Epidermal sensing of oxygen is essential for systemic hypoxic response. Cell 133(2):223-234.
13. Dang CV, Kim JW, Gao P, Yustein J (2008) The interplay between MYC and HIF in cancer. Nat Rev Cancer 8(1):51-56.
14. Ravi R, et al. (2000) Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev 14(1):34-44.
15. Bertout JA, et al. (2009) HIF2alpha inhibition promotes p53 pathway activity, tumor cell death, and radiation responses. Proc Natl Acad Sci USA 106(34):14391-14396.
16. Roberts AM, et al. (2009) Suppression of hypoxia-inducible factor 2alpha restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells. Cancer Res 69(23):9056-9064.
17. Brugarolas J, et al. (2004) Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 18(23):2893-2904.
18. Kline DD, Peng YJ, Manalo DJ, Semenza GL, Prabhakar NR (2002) Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1 alpha. Proc Natl Acad Sci USA 99(2):821-826.
19. Peng YJ, et al. (2011) Hypoxia-inducible factor 2α (HIF-2α) heterozygous-null mice exhibit exaggerated carotid body sensitivity to hypoxia, breathing instability, and hypertension. Proc Natl Acad Sci USA 108(7):3065-3070.
20. Nanduri J, et al. (2009) Intermittent hypoxia degrades HIF-2alpha via calpains resulting in oxidative stress: Implications for recurrent apnea-induced morbidities. Proc Natl Acad Sci USA 106(4):1199-1204.
21. Yuan G, et al. (2013) Mutual antagonism between hypoxia-inducible factors 1α and 2α regulates oxygen sensing and cardio-respiratory homeostasis. Proc Natl Acad Sci USA 110(19):E1788-E1796.
22. Takeda N, et al. (2010) Differential activation and antagonistic function of HIF-alpha isoforms in macrophages are essential for NO homeostasis. Genes Dev 24(5):491-501.
23. Boegehold MA (2010) Endothelium-dependent control of vascular tone during early postnatal and juvenile growth. Microcirculation 17(5):394-406.
24. Qiu C, Muchant D, Beierwaltes WH, Racusen L, Baylis C (1998) Evolution of chronic nitric oxide inhibition hypertension: Relationship to renal function. Hypertension 31(1):21-26.
25. Nagai M, et al. (2011) Role of blood cell-associated angiotensin II type 1 receptors in the cerebral microvascular response to ischemic stroke during angiotensin-induced hypertension. Exp Transl Stroke Med 3:15.
26. Munder M, Eichmann K, Modolell M (1998) Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: Competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J Immunol 160(11): 5347-5354.
27. Melillo G, et al. (1995) A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 182(6):1683-1693.
28. Carter R, 3rd, Wilson TE, Watenpaugh DE, Smith ML, Crandall CG (2002) Effects of mode of exercise recovery on thermoregulatory and cardiovascular responses. J Appl Physiol 93(6):1918-1924.
29. Marques FZ, Campain AE, Yang YH, Morris BJ (2010) Meta-analysis of genome-wide gene expression differences in onset and maintenance phases of genetic hypertension. Hypertension 56(2):319-324.
30. Ye P, West MJ (2003) Cosegregation analysis of natriuretic peptide genes and blood pressure in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 30(12): 930-936.
31. Vital SA, Terao S, Nagai M, Granger DN (2010) Mechanisms underlying the cerebral microvascular responses to angiotensin II-induced hypertension. Microcirculation 17(8):641-649.
32. Sanchez-Lopez E, et al. (2005) Angiotensin II regulates vascular endothelial growth factor via hypoxia-inducible factor-1alpha induction and redox mechanisms in the kidney. Antioxidants & redox signaling 7(9-10):1275-1284.
33. Vitek MP, et al. (2006) Characterization of NO and cytokine production in immuneactivated microglia and peritoneal macrophages derived from a mouse model expressing the human NOS2 gene on a mouse NOS2 knockout background. Antioxidants & redox signaling 8(5-6):893-901.
34. Vecchione C, et al. (2009) Pressure-induced vascular oxidative stress is mediated through activation of integrin-linked kinase 1/betaPIX/Rac-1 pathway. Hypertension 54(5):1028-1034.
35. Qiu C, Engels K, Samsell L, Baylis C (1995) Renal effects of acute amino acid infusion in hypertension induced by chronic nitric oxide blockade. Hypertension 25(1):61-66.
36. Vecchione C, et al. (2005) Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kgamma. J Exp Med 201(8):1217-1228.
37. Mason RP, et al. (2009) Loss of arterial and renal nitric oxide bioavailability in hypertensive rats with diabetes: Effect of beta-blockers. Am J Hypertens 22(11):1160-1166.
38. Hermann M, Flammer A, Lüscher TF (2006) Nitric oxide in hypertension. J Clin Hypertens (Greenwich) 8(12, Suppl 4):17-29.
39. Ghasemi A, Zahediasl S, Syedmoradi L, Azizi F (2011) Association between serum nitric oxide metabolites and hypertension in a general population. Int Angiol 30(4):380-387.
40. Dong JY, et al. (2011) Effect of oral L-arginine supplementation on blood pressure: A meta-analysis of randomized, double-blind, placebo-controlled trials. Am Heart J 162(6):959-965.
41. Gokce N (2004) L-arginine and hypertension. J Nutr 134(10 Suppl):2807S-2811S; discussion 2818S-2819S.
42. Committee on Care and Use of Laboratory Animals (1985) Guide for the Care and Use of Laboratory Animals (Natl Inst Health, Bethesda), DHHS Publ No (NIH) 85-23.
43. Feng M, et al. (2008) Validation of volume-pressure recording tail-cuff blood pressure measurements. Am J Hypertens 21(12):1288-1291.